Trial watch: Dendritic cell-based anticancer therapy

The use of patient-derived dendritic cells (DCs) as a means to elicit therapeutically relevant immune responses in cancer patients has been extensively investigated throughout the past decade. In this context, DCs are generally expanded, exposed to autologous tumor cell lysates or loaded with specif...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncoimmunology
Päätekijät: Bloy, Norma, Pol, Jonathan, Aranda, Fernando, Eggermont, Alexander, Cremer, Isabelle, Fridman, Wolf Hervé, Fučíková, Jitka, Galon, Jérôme, Tartour, Eric, Spisek, Radek, Dhodapkar, Madhav V., Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2014
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292311/
https://ncbi.nlm.nih.gov/pubmed/25941593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.963424
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia